clinical trial · NCT06696014
Mirikizumab Real World Protocol
University of North Carolina, Chapel Hill·—·recruiting·n = 100
Ulcerative Colitis
brief summary
The goal of this observational study is to learn about how effective mirikizumab (Omvoh) is when treating patients with ulcerative colitis (UC) Does mirikizumab (Omvoh) lead to a reduction in symptoms at intervals throughout one year? Participants being prescribed mirikizumab (Omvoh) as part of their regular medical care for UC will answer online survey questions about their bowel habits for 1 year.
started
May 8, 2025
primary completion
Jan 1, 2030
completion
Jan 1, 2030
last updated
Jul 9, 2025
official title
MIrikizumab in UC - a Real-woRld prOspective multicenteR Registry
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol